Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

Woman wearing a lab coat looking at a computer screen

AMR is increasingly predicted to affect health and wellbeing on an international scale. New technologies and greater understanding are required to mitigate against and reduce resistance to effective treatments against infectious diseases around the world.

Since 2017, the centre based in Oxford has coordinated the implementation of an AMR monitoring project at reference sites in India, the Philippines, Nigeria, and Colombia and has already helped improve the detection and tracking of outbreaks and AMR populations. The full results of the project can be read in a special edition of Clinical Infectious Diseases. The project’s partners were Dr Ravikumar at the Kempegowda Institute of Medical Sciences in India, Dr Celia Carlos at Research Institute for Tropical Medicine in the Philippines, Professor Iruka N. Okeke at the University of Ibadan in Nigeria, and Dr Pilar Godoy at AGROSAVIA in Colombia.

Read the full story on the Big Data Institute website